Why There *Still* Isn’t a Routine Screening Exam for Ovarian Cancer
Ovarian cancer lacks reliable early screening, but new research is exploring Pap smear–based tests and fallopian tube–focused prevention strategies. Emerging treatments, including targeted antibody-drug conjugates, are offering more precise options with fewer side effects.
APRENDE MÁS
VER TODAS LAS NOTICIAS
Mensajes recientes
5 Healthy Habits That Help During Cancer Treatment
Understanding Mammogram Results
A 19-Year Fight Against Prostate Cancer Brings Man to Johns Hopkins Medicine
Scientists Advance Efforts to Create ‘Virtual Cell Lab’ As Testing Ground for Future Research with Live Cells
Ultra-Processed Foods: Q&A with 2 Dietitians
Radiation Therapy Overcomes Immunotherapy Resistance in Some Cancers
‘Power Surges’ on Cancer Cell Membranes May Fuel Progression of Disease
New Cancer Target Discovered
How surgeons build a new bladder for cancer patients like Deion Sanders